Business
Lumicell Appoints Biotech and Medtech Leader Cheryl R. Blanchard, Ph.D., to Board of Directors
Lumicell, Inc., a leader in developing innovative fluorescence-guided imaging technologies for cancer detection, today announced the appointment of Cheryl R. Blanchard, Ph.D., to its Board of Directors. Dr. Blanchard is an accomplished biotech and medtech CEO and board member with more than 30 years of experience building, scaling, and transforming public and private life sciences companies.
About this update from Anika Therapeutics Inc.
[{"type":"text","content":"NEWTON, Mass., Feb. 4, 2026 /PRNewswire/ -- Lumicell, Inc., a leader in developing innovative fluorescence-guided imaging technologies for cancer detection, today announced the appointment of Cheryl R. Blanchard, Ph.D., to its Board of Directors. Dr. Blanchard is an accomplished biotech and medtech CEO and board member with more than 30 years of experience building, scaling, and transforming public and private life sciences companies.","length":438,"tagName":"p"},{"type":"image","alt":"Cheryl R. Blanchard, Ph.D. Joins Lumicell Board of Directors","displaySize":"","headline":null,"caption":"Cheryl R. Blanchard, Ph.D. Joins Lumicell Board of Directors","className":"","disableSlideshowImg":false,"size":{"original":{"width":327,"height":400,"url":"https://media.zenfs.com/en/prnewswire.com/9d91b87c971d131350e6fc8ed9f0986f"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/fbx6udE0NK.oBY2Ic1Z_9A--/YXBwaWQ9aGlnaGxhbmRlcjt3PTY0MDtoPTc4MztjZj13ZWJw/https://media.zenfs.com/en/prnewswire.com/9d91b87c971d131350e6fc8ed9f0986f","width":327,"height":400}},"href":"https://mma.prnewswire.com/media/2876397/Lumicell_Cheryl_Blanchard_PhD.html","hrefExternal":true,"rel":"nofollow"},{"type":"text","content":"Dr. Blanchard most recently served as President, CEO, and Director of Anika Therapeutics (NASDAQ: ANIK), where she led the successful implementation of a high-growth commercial strategy. During her tenure, Anika divested non-core assets, commercialized innovative regenerative orthopedic and osteoarthritis pain products, delivered double-digit commercial channel growth, and advanced multiple programs through U.S. clinical and regulatory pathways. Dr. Blanchard will remain on the Anika Board as Executive Chair.","length":514,"tagName":"p"},{"type":"text","content":"Her prior leadership roles include serving as CEO of Microchips Biotech and as Senior Vice President & Chief Scientific Officer of Zimmer.","length":142,"tagName":"p"},{"type":"text","content":""Cheryl brings a rare combination of scientific depth, operational rigor, commercial leadership, and board experience—paired with a proven track record of transforming organizations and launching category-defining products," said Andrey J. Zarur, Ph.D., Co-Founder & Chairman of the Board of Directors of Lumicell. "Her strategic acumen and her commitment to patient-focused...